ASTRAZEN.NS - AstraZeneca Pharma India Limited

NSE - NSE Real Time Price. Currency in INR

AstraZeneca Pharma India Limited

Manyata Embassy Business Park
Block N1, 12th Floor
Bengaluru 560045
91 80 6774 8000

IndustryDrug Manufacturers - Major
Full Time Employees1,141

Key Executives

Mr. Gagandeep Singh BediMD & Exec. DirectorN/AN/A46
Mr. Rajesh MarwahaCFO & Whole Time Director4.09MN/A54
Mr. Pratap B. RudraLegal Counsel, Compliance Officer & Company Sec.807.41kN/AN/A
Mrs. Smita SahaVP of HRN/AN/A47
Mr. Sanjeev PanchalBus. Unit Head - ACSN/AN/A40
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It operates in two segments, Healthcare and Others. The company offers products in the areas of cardiovascular and metabolic, oncology, neuroscience, and gastrointestinal, as well as respiratory, inflammation, and autoimmunity diseases; and infection and vaccine products under the Brilinta, Betaloc, Seloken XL, Imdur, Crestor, Forxiga, Onglyza, Kombiglyze XR, Byetta, Symbicort, Arimidex, Nolvadex, Iressa, Zoladex, Casodex, Faslodex, and Tagrisso brands. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca PLC.

Corporate Governance

AstraZeneca Pharma India Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.